eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Documenthome » Draft Guidance for Industry; Availability: Oversight of Clinical Investigations; A Risk-Based Approach to Monitoring

Draft Guidance for Industry; Availability: Oversight of Clinical Investigations; A Risk-Based Approach to Monitoring

Document ID: FDA-2011-D-0597-0001

Comments

Total: 34
Invivodata, Inc. - Comment
Posted : 12/05/2011     ID ：FDA-2011-D-0597-0041     Agency : FDA

Nov 28,2011 11:59 PM ET
Timothy King - Comment
Posted : 12/05/2011     ID ：FDA-2011-D-0597-0042     Agency : FDA

Nov 28,2011 11:59 PM ET
Association of Clinical Research Professionals (ACRP) - Comment
Posted : 12/09/2011     ID ：FDA-2011-D-0597-0043     Agency : FDA

Nov 28,2011 11:59 PM ET
Society for Clinical Data Management (SCDM) - Comment
Posted : 12/23/2011     ID ：FDA-2011-D-0597-0049     Agency : FDA

Nov 28,2011 11:59 PM ET